moneyheap
DOC · Analysis updated Nov 10, 2026, 6:00 PM ET
Why is Healthpeak Properties, Inc. (DOC) stock moving?
DOC rose from $18.55 on Oct 28 to $20.41 on Nov 10, about 10% higher, after a strong Q3 2026 report on Nov 2. Adjusted FFO of $0.44 beat the $0.43 estimate, revenue of $820.9M beat the $736.8M estimate, and full-year FFO guidance was raised to $1.76-$1.78 from $1.73-$1.77, above the $1.76 consensus. Volume spiked to 9.6M and 9.9M shares on Nov 2-3, against a typical 4.5-7M, and has since eased to 5.1M on Nov 10, so the post-earnings interest is fading. Leasing was active: Outpatient Medical executed 846,000 sq ft in Q3 and Lab executed 480,000 sq ft, with a further 1.3M and 643,000 sq ft executed or under LOI after quarter-end. Segment trends diverge: Senior Housing same-store NOI rose 25.9%, Outpatient Medical rose 3.1%, and Lab fell 0.7%. Janus Living revenue rose 78% and adjusted EBITDAre rose 101%. Risks include Q3 FFO of $0.44 versus $0.46 a year earlier, net debt at 4.7x adjusted EBITDAre, and $1.75B of senior housing acquisitions. Analyst views are mixed: Evercore is In-Line with a $23 target, while Cantor is Neutral with its target cut to $21, close to the current price.
News behind the analysis
- Evercore ISI Group Maintains In-Line on Healthpeak Properties, Raises Price Target to $23Evercore ISI kept its In-Line rating on Healthpeak and raised its price target to $23.
- Cantor Fitzgerald Adjusts Healthpeak Properties Price Target to $21 From $23Cantor Fitzgerald lowered its Healthpeak price target from $23 to $21 per share.
- Cantor Fitzgerald Maintains Neutral on Healthpeak Properties, Lowers Price Target to $21Cantor kept a Neutral rating on Healthpeak while cutting its price target to $21.
- Healthpeak Properties Q3 2026 Earnings Call TranscriptTranscript of the Q3 2026 earnings call, held Tuesday, Nov 3, where Healthpeak reported third-quarter results.
- Healthpeak Properties Reports Third Quarter 2026 Results and Increases Full Year 2026 Earnings GuidanceQ3 FFO as Adjusted was $0.44 per share, with Outpatient Medical leases of 846,000 sq ft and Lab leases of 480,000 sq ft. The company also raised its full-year 2026 earnings guidance and reported Janus Living revenue up 78% year over year.
- Healthpeak Properties Raises FY2026 FFO Guidance from $1.73-$1.77 to $1.76-$1.78 vs $1.76 EstFull-year 2026 FFO guidance was raised to $1.76-$1.78 from $1.73-$1.77, above the $1.76 consensus estimate.
- Healthpeak Properties Q3 Adj. FFO $0.44 Beats $0.43 Estimate, Sales $820.892M Beat $736.787M EstimateQ3 adjusted FFO of $0.44 beat the $0.43 estimate, and sales of $820.9M beat the $736.8M estimate.
About Healthpeak Properties, Inc.
Healthpeak Properties is a Denver-based S&P 500 real estate investment trust that owns, runs and develops healthcare real estate across the US. At mid-2026 it had interests in roughly 690 properties, mostly outpatient medical buildings, plus life-science labs and senior housing. It pays a monthly dividend and holds a majority stake in Janus Living, a senior-housing REIT it spun out in a 2026 IPO.
How it makes money
Most of its income is rent. Health systems and doctors lease its outpatient medical buildings (about 500 properties, its biggest segment), and biotech and pharma companies lease its lab campuses (about 140 properties, many in Boston, San Francisco and San Diego). It also earns operating income from senior-housing communities, run under a structure where it keeps the properties' operating profits rather than a fixed rent. Much of this now sits in Janus Living, which a Healthpeak subsidiary manages for a fee and which Healthpeak owned about 69% of as of late 2026. Smaller amounts come from loans and other investments.
What usually moves DOC
- Interest rates and refinancing costs
- Biotech funding and lab leasing demand
- Outpatient medical occupancy and rent growth
- Senior housing occupancy
- Funds-from-operations guidance and dividend coverage